| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Guest Access | Sign In via User Name/Password
|
|
|
|||||||
Guest Access | Sign In via User Name/Password |
|||||||||
1 From the Department of Medicine, Saint Louis University Health Sciences Center, St. Louis
2 From the Departments of Pathology, Surgery, and Medicine, Baylor College of Medicine and The Methodist Hospital, Houston
Thirty-two recipients of single, double, or heart-lung transplantation followed-up for at least 3 months posttransplant were retrospectively reviewed to assess the frequency, predictors, and risk factors associated with the development of bronchiolitis obliterans (BO). A clinical definition for the diagnosis of BO was made using the following criteria: persistent and progressive decline in FEF25-75, associated with normal results of cytologic and microbiologic studies for significant pathogens in bronchoalveolar lavage fluid, with a normal chest radiograph. This was correlated with histologic diagnosis and patient outcome. Sixteen (50%) of the patients developed BO, and this was associated with a 56% mortality. All but 1 patient with histologic BO had a clinical diagnosis of BO made (often months) prior to diagnostic biopsy. No patients with normal histologic findings had a clinical diagnosis of BO. More than 3 episodes of histologically documented acute rejections in any 12-month period were eventually associated with a 100% incidence of BO. Cytomegalovirus occurred with greater frequency in patients with BO, and in most cases, preceded or occurred concomitantly with the diagnosis of acute rejection or BO.
Key Words: acute rejection • bronchiolitis obliterans • cytomegalovirus disease • lung transplantation • pulmonary function testing
Submitted on August 20, 1993
Accepted on September 21, 1994
This article has been cited by other articles:
|
|
 |
|
  G. Warnecke, M. Avsar, T. Steinkamp, R. Reinhard, J. Niedermeyer, A. R. Simon, A. Haverich, and M. Struber Tacrolimus versus cyclosporine induction therapy in pulmonary transplantation in miniature swine Eur. J. Cardiothorac. Surg., September 1, 2005; 28(3): 454 - 460. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Tamm, C. L. Aboyoun, P. N. Chhajed, S. Rainer, M. A. Malouf, and A. R. Glanville Treated Cytomegalovirus Pneumonia Is Not Associated with Bronchiolitis Obliterans Syndrome Am. J. Respir. Crit. Care Med., November 15, 2004; 170(10): 1120 - 1123. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Konen, C. Gutierrez, C. Chaparro, C. P. Murray, T. Chung, J. Crossin, M. A. Hutcheon, N. S. Paul, and G. L. Weisbrod Bronchiolitis Obliterans Syndrome in Lung Transplant Recipients: Can Thin-Section CT Findings Predict Disease before Its Clinical Appearance? Radiology, May 1, 2004; 231(2): 467 - 473. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Hadjiliadis, R. D. Davis, and S. M. Palmer Is Transplant Operation Important in Determining Posttransplant Risk of Bronchiolitis Obliterans Syndrome in Lung Transplant Recipients? Chest, October 1, 2002; 122(4): 1168 - 1175. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D.M. Hansell Small airways diseases: detection and insights with computed tomography Eur. Respir. J., June 1, 2001; 17(6): 1294 - 1313. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E.-S. Lee, M. B. Gotway, G. P. Reddy, J. A. Golden, F. M. Keith, and W. R. Webb Early Bronchiolitis Obliterans Following Lung Transplantation: Accuracy of Expiratory Thin-Section CT for Diagnosis Radiology, August 1, 2000; 216(2): 472 - 477. [Abstract] [Full Text]
|
|
|
|
 |
|
 J. A. Belperio, M. D. Burdick, M. P. Keane, Y. Y. Xue, J. P. Lynch III, B. L. Daugherty, S. L. Kunkel, and R. M. Strieter The Role of the CC Chemokine, RANTES, in Acute Lung Allograft Rejection J. Immunol., July 1, 2000; 165(1): 461 - 472. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. REYNAUD-GAUBERT, P. THOMAS, M. BADIER, P. CAU, R. GIUDICELLI, and P. FUENTES Early Detection of Airway Involvement in Obliterative Bronchiolitis after Lung Transplantation . Functional and Bronchoalveolar Lavage Cell Findings Am. J. Respir. Crit. Care Med., June 1, 2000; 161(6): 1924 - 1929. [Abstract] [Full Text]
|
|
|
|
 |
|
 S. J. Swanson, S. J. Mentzer, J. J. Reilly, R. Bueno, J. M. Lukanich, M. T. Jaklitsch, L. Kobzik, E. P. Ingenito, A. Fuhlbrigge, C. Donovan, et al. SURVEILLANCE TRANSBRONCHIAL LUNG BIOPSIES: IMPLICATION FOR SURVIVAL AFTER LUNG TRANSPLANTATION J. Thorac. Cardiovasc. Surg., January 1, 2000; 119(1): 27 - 38. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Longoria, R. F. Roberts, C. C. Marboe, B. C. Stouch, V. A. Starnes, and M. L. Barr SIROLIMUS (RAPAMYCIN) POTENTIATES CYCLOSPORINE IN PREVENTION OF ACUTE LUNG REJECTION J. Thorac. Cardiovasc. Surg., April 1, 1999; 117(4): 714 - 718. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Trello, D. Williams, C. Keller, C Crim, R. Webster, and J. Ohar Increased gelatinolytic activity in bronchoalveolar lavage fluid in stable lung transplant recipients Am. J. Respir. Crit. Care Med., December 1, 1997; 156(6): 1978 - 1986. [Abstract] [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
